FTC Chair Lina Khan (Photo by Michael Brochstein/Sipa USA)(Sipa via AP Images)
September 14, 2023 12:28 PM EDTUpdated 02:04 PM
Pharma

FTC is­sues pol­i­cy con­demn­ing the im­prop­er list­ing of patents in FDA's Or­ange Book

Zachary Brennan

Senior Editor

The Fed­er­al Trade Com­mis­sion vot­ed 3-0 on Thurs­day to is­sue a pol­i­cy state­ment to in­crease scruti­ny of im­prop­er list­ing of patents in the FDA’s Or­ange …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times